[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, A Carson-Stevens, LM Yu, P Little, AA Agyeman… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis

AA Agyeman, KL Chin, CB Landersdorfer, D Liew… - Mayo Clinic …, 2020 - Elsevier
… Author links open overlay panel Akosua Adom Agyeman MSc a , Ken L. Chin MClinPharm,
PhD b c , Cornelia B. Landersdorfer PhD a , Danny Liew MBBS (Hons), FRACP, PhD b , …

[HTML][HTML] Irrational use of medicines—a summary of key concepts

R Ofori-Asenso, AA Agyeman - Pharmacy, 2016 - mdpi.com
Medicines play an integral part of healthcare delivery. However, they are expensive commodities
and account for a significant proportion of overall health expenditure in most countries. …

[HTML][HTML] Overweight and obesity epidemic in Ghana—a systematic review and meta-analysis

R Ofori-Asenso, AA Agyeman, A Laar, D Boateng - BMC public health, 2016 - Springer
Background In many low and middle income countries (LMICs), the distribution of adulthood
nutritional imbalance is shifting from a predominance of undernutrition to overnutrition. This …

[HTML][HTML] Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015)

R Ofori-Asenso, AA Agyeman - BMC infectious diseases, 2016 - Springer
Background Although, chronic hepatitis B (HBV) is considered to be of significant public health
importance in Ghana, not many reviews detailing the burden (prevalence) of the disease …

[HTML][HTML] Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and …

AA Agyeman, R Ofori-Asenso - Annals of clinical microbiology and …, 2016 - Springer
Background Treatment options for drug-resistant tuberculosis are still limited. Linezolid has
been recommended for treatment of patients with multidrug-resistant (MDR) or extensively-…

[HTML][HTML] Perspective: Does personalized medicine hold the future for medicine?

AA Agyeman, R Ofori-Asenso - Journal of Pharmacy and Bioallied …, 2015 - journals.lww.com
W ith the upsurge of personalizing virtually anything such as mugs, stationery, T‑shirts,
phone cases, gift items and most recently the ongoing personalized Coca‑Cola UK summer …

A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections

AA Agyeman, PJ Bergen, GG Rao, RL Nation… - International journal of …, 2020 - Elsevier
Introduction Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a major
global public health challenge. This study aimed to systematically review the evidence on …

Tuberculosis—an overview

AA Agyeman, R Ofori-Asenso - Journal of Public Health and …, 2017 - jphe.amegroups.org
Tuberculosis (TB) remains one of the deadliest infectious diseases responsible for millions
of deaths annually across the world. In this paper we present a general overview of TB …

[HTML][HTML] Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis

R Ofori-Asenso, O Ogundipe, AA Agyeman… - …, 2020 - ncbi.nlm.nih.gov
Cancer patients are vulnerable to complications of respiratory viruses. This systematic review
and meta-analysis sought to examine the prevalence of cancer and its association with …